Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1551607

CCNCc1ccccc1.Cl

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA known ✓ P10253 2/20 0.58
MAOA known ✓ P21397 1/20 0.54
CHRM2 known ✓ P08172 1/20 0.52
SIGMAR1 known ✓ Q99720 1/20 0.48
CA2 known ✓ P00918 1/20 0.47
MEN1 O00255 1/20 0.61
KMT2A Q03164 1/20 0.61
TDP1 Q9NUW8 1/20 0.61
MAPT P10636 3/20 0.58
CYP3A4 P08684 2/20 0.58
KDM4E B2RXH2 1/20 0.58
PKM P14618 1/20 0.55
ADH1B P00325 1/20 0.48
ADH1C P00326 1/20 0.48
ADH1A P07327 1/20 0.48
ADH7 P40394 1/20 0.48
IDO1 P14902 2/20 0.48
THRB P10828 1/20 0.48
TP53 P04637 1/20 0.48
CA1 P00915 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2146 0.97 MEN1 (0.64) MEN1KMT2ATDP1MAPTCYP3A4
Benzene SCHEMBL7471176 0.97 MEN1 (0.64) MEN1KMT2ATDP1MAPTCYP3A4
Lithium SCHEMBL31374748 0.95 MEN1 (0.61) MEN1KMT2ATDP1MAPTCYP3A4
Bromide SCHEMBL7087997 0.95 MEN1 (0.61) MEN1KMT2ATDP1MAPTCYP3A4
Water SCHEMBL1868146 0.95 MEN1 (0.61) MEN1KMT2ATDP1MAPTCYP3A4
Iodide SCHEMBL17241299 0.95 MEN1 (0.61) MEN1KMT2ATDP1MAPTCYP3A4
Ammonia Solution, Strong SCHEMBL3582415 0.95 MEN1 (0.61) MEN1KMT2ATDP1MAPTCYP3A4
SCHEMBL10813092 0.95 MEN1 (0.61) MEN1KMT2ATDP1MAPTCYP3A4
SCHEMBL21065761 0.95 MEN1 (0.61) MEN1KMT2ATDP1MAPTCYP3A4
Dimethylamine SCHEMBL1478208 0.93 MEN1 (0.58) MEN1KMT2ATDP1MAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 382 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117584584-B Full polyethylene type composite film and preparation method thereof 惠州市道科包装材料有限公司 2025-05-27 CN claimed
CN-119875145-A Nitrile rubber emulsion separation method, modified epoxy resin, preparation method and application thereof, and epoxy resin compound 麦克奥迪(厦门)智能电气有限公司 2025-04-25 CN claimed
US-20240216298-A1 TOPICAL TREATMENT OF HERPES INFECTIONS TECH SWERVE, LLC 2024-07-04 US claimed
WO-2023200764-A1 NANOEMULSION UNIVERSAL INFLUENZA VACCINE BLUEWILLOW BIOLOGICS, INC. (US) 2023-10-19 WO claimed
US-20230257682-A1 FABRIC CARE COMPOSITIONS WITH DOSE-DEPENDENT ANTIMICROBIAL ACTIVITIES THAT REDUCE THE RISK OF INFECTION AND PROMOTE HEALTH AND HYGIENE WHEN USED DISCRETELY OR SYNERGISTICALLY IN A MACHINE WASHING AND DRYING LAUNDRY PROGRAM TJBS IP Management, LLC (US) 2023-08-17 US claimed
EP-4121220-A1 PLASMA COATING TREATMENT METHOD FOR INHIBITING BIOLOGICAL PATHOGEN TRANSFER Molecular Plasma Group SA (LU) 2023-01-25 EP claimed
CN-115605297-A Plasma coating treatment method for inhibiting transfer of biological pathogens 分子等离子集团股份有限公司(LU) 2023-01-13 CN claimed
EP-3956314-A1 PREPARATION OF SUBSTITUTED PYRAZOLES AND THEIR USE AS ANTHRANILAMIDES PRECURSORS Adama Makhteshim Ltd. (IL) 2022-02-23 EP claimed
WO-2021185933-A1 PLASMA COATING TREATMENT METHOD FOR INHIBITING BIOLOGICAL PATHOGEN TRANSFER MOLECULAR PLASMA GROUP S.A. (LU) 2021-09-23 WO claimed
EP-3881942-A1 PLASMA COATING TREATMENT METHOD FOR INHIBITING BIOLOGICAL PATHOGEN TRANSFER Molecular Plasma Group SA (LU) 2021-09-22 EP claimed
CN-1183268-A Detergent composition KAO CORP (JP) 1998-06-03 CN claimed
WO-1998011778-A1 ANTIMICROBIAL TREATMENT FOR HERPES SIMPLEX VIRUS AND OTHER INFECTIOUS DISEASES SQUIRES MERYL (US) 1998-03-26 WO claimed
US-5622708-A Erodible sanitizing caulk ECOLAB INC. (US) 1997-04-22 US claimed
EP-0623166-B1 LIQUID HARD SURFACE DETERGENT COMPOSITIONS CONTAINING ZWITTERIONIC AND CATIONIC DETERGENT SURFACTANTS AND MONOETHANOLAMINE AND/OR BETA-AMINOALKANOL PROCTER & GAMBLE (US) 1996-06-05 EP claimed
EP-0623166-A1 LIQUID HARD SURFACE DETERGENT COMPOSITIONS CONTAINING ZWITTERIONIC AND CATIONIC DETERGENT SURFACTANTS AND MONOETHANOLAMINE AND/OR BETA-AMINOALKANOL. PROCTER & GAMBLE (US) 1994-11-09 EP claimed
EP-0610302-A1 METHOD OF ANALYSIS CTS BIOCIDES LTD. (GB) 1994-08-17 EP claimed
WO-1993015173-A1 LIQUID HARD SURFACE DETERGENT COMPOSITIONS CONTAINING ZWITTERIONIC AND CATIONIC DETERGENT SURFACTANTS AND MONOETHANOLAMINE AND/OR BETA-AMINOALKANOL THE PROCTER & GAMBLE COMPANY (US) 1993-08-05 WO claimed
WO-1993009430-A1 METHOD OF ANALYSIS CTS BIOCIDES LTD. (GB) 1993-05-13 WO claimed
EP-0255664-A2 Process for the preparation of dimeric aromatic acylcyanides BAYER AG (DE) 1988-02-10 EP claimed
US-4576649-A HETEROPOLY ACIDS, BASIC RED DYES, AMMONIUM AND QUATERNARY AMMONIUM SALTS MOBAY CHEMICAL CORPORATION (US) 1986-03-18 US claimed